{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:27:42Z","timestamp":1788452862622,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["823250290"],"award-info":[{"award-number":["823250290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171379"],"award-info":[{"award-number":["32171379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472123"],"award-info":[{"award-number":["82472123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20156"],"award-info":[{"award-number":["U22A20156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016082","name":"JiangXi Province Human Resources and Social Security Department","doi-asserted-by":"publisher","award":["2022DJ02"],"award-info":[{"award-number":["2022DJ02"]}],"id":[{"id":"10.13039\/100016082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFA1100700"],"award-info":[{"award-number":["2021YFA1100700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["2022YYGFZJC006"],"award-info":[{"award-number":["2022YYGFZJC006"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.actbio.2025.01.021","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T09:11:41Z","timestamp":1737191501000},"page":"153-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy"],"prefix":"10.1016","volume":"194","author":[{"given":"Jiaxuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuirong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4889-4017","authenticated-orcid":false,"given":"Xiandi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbao","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huating","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-9578","authenticated-orcid":false,"given":"Yuning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-4532","authenticated-orcid":false,"given":"Tianmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.actbio.2025.01.021_bib0001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","article-title":"The foundations of immune checkpoint blockade and the ipilimumab approval decennial","volume":"21","author":"Korman","year":"2022","journal-title":"Nat. Rev. Drug Disc."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(20)30754-3","article-title":"Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial","volume":"22","author":"Winer","year":"2021","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.actbio.2025.01.021_bib0003","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.annonc.2021.05.355","article-title":"First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: iMpassion130 final overall survival analysis","volume":"32","author":"Emens","year":"2021","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.01.021_bib0004","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2025.01.021_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance mechanisms to anti-PD cancer immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2025.01.021_bib0006","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ccell.2021.08.005","article-title":"Activating a collaborative innate-adaptive immune response to control metastasis","volume":"39","author":"Sun","year":"2021","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.actbio.2025.01.021_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186968","article-title":"CD8 T cell score as a prognostic biomarker for triple negative breast cancer","volume":"21","author":"Oshi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.actbio.2025.01.021_bib0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0011","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41419-024-06616-7","article-title":"Advances in engineered macrophages: a new frontier in cancer immunotherapy","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.021_bib0012","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","article-title":"YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells","volume":"24","author":"Ma","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.actbio.2025.01.021_bib0014","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.148.6.1560","article-title":"The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity","volume":"148","author":"Berendt","year":"1978","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.actbio.2025.01.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.actbio.2025.01.021_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585146","article-title":"Lipopolysaccharide recognition in the crossroads of TLR4 and Caspase-4\/11 mediated inflammatory pathways","volume":"11","author":"Zamyatina","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2025.01.021_bib0017","series-title":"Treasure Island (FL) ineligible companies. Disclosure: Yusuf Khan declares no relevant financial relationships with ineligible companies., 2024","author":"Farhana","year":"2024"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0018","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1080\/10717544.2018.1469684","article-title":"A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides","volume":"25","author":"Shetab Boushehri","year":"2018","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.actbio.2025.01.021_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4155\/tde-2018-0076","article-title":"Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto","volume":"10","author":"Shetab Boushehri","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2025.01.021_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0021","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/s41467-022-31579-8","article-title":"An in situ hydrogel-mediated chemo-immunometabolic cancer therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.actbio.2025.01.021_bib0022","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1039\/D1BM00542A","article-title":"Near infrared light activation of an injectable whole-cell cancer vaccine for cancer immunoprophylaxis and immunotherapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2025.01.021_bib0023","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acsnano.8b07371","article-title":"Surgical tumor-derived personalized photothermal vaccine formulation for cancer immunotherapy","volume":"13","author":"Ye","year":"2019","journal-title":"ACS. Nano"},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0024","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.carbpol.2012.03.073","article-title":"Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity","volume":"89","author":"Shi","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2025.01.021_bib0025","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.2147\/IJN.S418534","article-title":"Progress in pluronic F127 derivatives for application in wound healing and repair","volume":"18","author":"Li","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0026","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejps.2011.04.015","article-title":"Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels","volume":"43","author":"Ye","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2025.01.021_bib0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10856-015-5493-4","article-title":"Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells","volume":"26","author":"Diniz","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0028","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/17425247.2020.1731469","article-title":"Formulation strategies to modulate drug release from poloxamer based in situ gelling systems","volume":"17","author":"Abdeltawab","year":"2020","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.021_bib0029","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejpb.2010.02.011","article-title":"A poloxamer\/chitosan in situ forming gel with prolonged retention time for ocular delivery","volume":"75","author":"Gratieri","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/gels8010044","article-title":"Chitosan\/Pluronic F127 thermosensitive hydrogel as an injectable dexamethasone delivery carrier","volume":"8","author":"Garc\u00eda-Couce","year":"2022","journal-title":"Gels."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.021_bib0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels\u2013review of temperature-sensitive systems","volume":"58","author":"Ruel-Gariepy","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2025.01.021_bib0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","article-title":"Recent progress in biomedical applications of pluronic (PF127): pharmaceutical perspectives","volume":"209","author":"Akash","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0033","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/viru.26083","article-title":"Animal models of sepsis","volume":"5","author":"Fink","year":"2014","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1753425918771170","article-title":"Inhibition of autophagy with 3-methyladenine is protective in a lethal model of murine endotoxemia and polymicrobial sepsis","volume":"24","author":"Li","year":"2018","journal-title":"Innate Immun."},{"issue":"111","key":"10.1016\/j.actbio.2025.01.021_bib0035","doi-asserted-by":"crossref","DOI":"10.3791\/53913","article-title":"Intravenous endotoxin challenge in healthy humans: an experimental platform to investigate and modulate systemic inflammation","author":"Fullerton","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0036","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/s41467-021-26940-2","article-title":"Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.actbio.2025.01.021_bib0038","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0039","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/0008-5472.CAN-20-1994","article-title":"Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.actbio.2025.01.021_bib0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41419-021-04293-4","article-title":"Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-\u03baB pathway in pancreatic cancer","volume":"12","author":"Yin","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"6917","key":"10.1016\/j.actbio.2025.01.021_bib0041","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2025.01.021_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5871431","article-title":"Sophocarpine attenuates LPS-induced liver injury and improves survival of mice through suppressing oxidative stress, inflammation, and apoptosis","volume":"2018","author":"Jiang","year":"2018","journal-title":"Mediators. Inflamm."},{"issue":"10","key":"10.1016\/j.actbio.2025.01.021_bib0043","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/PL00000229","article-title":"Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site","volume":"50","author":"Nemzek","year":"2001","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.021_bib0044","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ame2.12139","article-title":"Clinical hematological and biochemical parameters in Swiss, BALB\/c, C57BL\/6 and B6D2F1 Mus musculus","volume":"3","author":"Silva-Santana","year":"2020","journal-title":"Animal. Model. Exp. Med."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.021_bib0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3892\/ol.2015.3304","article-title":"Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.actbio.2025.01.021_bib0046","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0047","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.actbio.2025.01.021_bib0048","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2025.01.021_bib0049","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.actbio.2025.01.021_bib0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.actbio.2025.01.021_bib0051","first-page":"2524","article-title":"Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients","volume":"51","author":"Engelhardt","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2025.01.021_bib0052","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.biomaterials.2016.02.001","article-title":"Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot","volume":"85","author":"Kim","year":"2016","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2025.01.021_bib0053","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.apsb.2018.12.005","article-title":"Prussian blue nanosphere-embedded in situ hydrogel for photothermal therapy by peritumoral administration","volume":"9","author":"Fu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2025.01.021_bib0054","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mattod.2023.03.025","article-title":"In situ forming pH\/ROS-responsive niche-like hydrogel for ultrasound-mediated multiple therapy in synergy with potentiating anti-tumor immunity","volume":"65","author":"Dai","year":"2023","journal-title":"Mater. Today"},{"issue":"15","key":"10.1016\/j.actbio.2025.01.021_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202213867","article-title":"Bioresponsive self-reinforcing sericin\/silk fibroin hydrogel for relieving the immune-related adverse events in tumor immunotherapy","volume":"33","author":"Gou","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"48","key":"10.1016\/j.actbio.2025.01.021_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202204502","article-title":"Tumor-microenvironment-responsive cascade reactions by a cobalt-single-atom nanozyme for synergistic nanocatalytic chemotherapy","volume":"61","author":"Cai","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0057","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13045-021-01150-x","article-title":"Intracellular delivery of anti-BCR\/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.021_bib0058","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI121372","article-title":"TNF\/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy","volume":"129","author":"Sharma","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2025.01.021_bib0059","first-page":"38","article-title":"ROS-responsive 18\u03b2-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation","volume":"19","author":"Jin","year":"2023","journal-title":"Bioact. Mater."}],"updated-by":[{"DOI":"10.1016\/j.actbio.2026.06.044","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000}},{"DOI":"10.1016\/j.actbio.2026.06.044","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:41:46Z","timestamp":1785094906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"alternative-id":["S1742706125000261"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.021","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}